Objectives. We sought to investigate the postoperative complications of vestibular schwannoma excision and determine their significant clinical predictors.
Introduction
The past few decades have been witness to substantial changes in epidemiology, diagnostic modalities, and treatment philosophies of vestibular schwannoma (VS). 1 The incidence of VS has increased over recent decades mainly due to detection of increasingly smaller VS and heightened awareness of VS among clinicians. 2, 3 Identification of smaller tumors or tumors in earlier stages has contributed to development of hearing preserving surgery and nonsurgical treatment options. [4] [5] [6] Conservative treatment modalities such as radiosurgery and observation with serial imaging are gaining popularity. 4, [6] [7] [8] Since the introduction of microsurgery by Dr William House in 1961, intraoperative mortality is no longer commonplace. Intraoperative mortality rates, reported by multiple studies, are less than 1%. 6, 9, 10 The primary goals of VS excision have evolved to include preserving normal hearing and facial nerve function, as well as avoiding brainstem injury and mortality. [4] [5] [6] Despite improvements in surgical techniques, intraoperative monitoring, and neuroanesthesia, complications continue to occur with considerable incidence. 4 The complication rates vary greatly depending on surgical approach, tumor size, surgeon caseload, and other factors. [4] [5] [6] 9 Additionally, VS excisions have become increasingly centralized to higher volume centers, 3 and several studies have reported that surgeries in high volume centers are associated with fewer postoperative complications. 11, 12 Amid these dramatic changes in the treatment landscape of VS, our study aimed to capture how postoperative complication rates have evolved over the past 2 decades using the California Hospital Inpatient Discharge Datasets. Furthermore, we sought to investigate whether the incidence of postoperative complications could be correlated to potential predictors.
Methods

Data Source
The California Hospital Inpatient Discharge Datasets from 1997 to 2011 were obtained and merged. These data sets, collected by the California Office of Statewide Health Planning and Development (OSHPD), include data on all inpatient discharges from all licensed hospitals in California. The data sets are released in form of de-identified records that contain patient-level data such as demographics and diagnoses and procedures coded through International Classification of Diseases, 9th edition, Clinical Modification (ICD-9-CM). Information on data collection instruments and methodology is available on the website of OSHPD. 13 The data set does not contain identifiable patient information; thus, approval for this study by our institutional review board was not required.
The merged 1997-2011 data sets were reviewed and all cases enlisting the ICD-9-CM procedure code ''04.01 excision of acoustic neuroma'' were extracted. Neurofibromatosis type II cases were identified and excluded using the ICD-9-CM diagnosis code, ''237.72 neurofibromatosis, type 2 [acoustic neurofibromatosis].'' Seventeen cases with unspecified neurofibromatosis codes were also excluded due to potential miscoding.
Variables and Definitions
The outcome variables were (1) the proportion of patients who suffered from neurological complications, (2) the proportion of patients who suffered from medical complications, and (3) the proportion of patients who died, required ''further care,'' or was not discharged directly. ''Further care'' included patients who were admitted to acute or long-term care facilities within the hospital or transferred to another hospital. The perioperative complications were identified through a review of the literature [14] [15] [16] and defined using the ICD-9-CM diagnosis and procedure codes ( Table 1) . Since the comorbidities and complications could have been present at any point during admission, it was difficult to determine whether hearing loss and tinnitus occurred pre-or postoperatively, and thus they were not analyzed.
The independent variables examined were as follows: years of study were grouped into three 5-year periods, 1997-2001, 2002-2006, and 2007-2011 . Demographics including age (1-17, 18-64, and 65 years or older), gender, and ethnicity (Caucasian vs. non-Caucasian) were analyzed. Principal payer was recoded as Medicare, Medi-Cal (California's version of Medicaid, state program for the poor), private (ie, HMO or PPO), and other (ie, self-pay, worker's compensation, charity, county indigent programs, or other government and indigent programs: including outof-state Medicaid). State of residence was classified into California versus other (ie, out of state, homeless), based on the recorded zip codes. Comorbidities were defined using ICD-9-CM diagnosis codes ( Table 1) . Hospital case volume was categorized into 0-99 cases and 100 or more cases over the study period.
Statistical Analyses
Changes in outcomes of surgeries were analyzed and their correlation with time was evaluated using linear regression analysis. Mean 6 standard deviation (SD) was calculated for age. A multivariate logistic regression model was fit to determine whether any of the independent variables were associated with the occurrence of the neurological and medical complications, as well as patients who died or required further care. The output of the multivariate analysis was reported as odds ratio (OR) and 95% confidence interval (CI). Data analysis was performed using PASW Statistics 18.0 (SPSS, Inc., Chicago, Illinois). A P value of less than .05 was considered significant. Males comprised 48.5%, Caucasians comprised 82.9%, and California residents comprised 69.7% of this patient population. The principal payer was private insurance in 76.3%, Medicare in 10.7%, Medi-Cal in 3.5%, and ''other'' in 9.5% of cases. Comorbidities were present in 38.7% of the cases (2539 patients) ( Table 2 ). The most common comorbidities were hypertension (21.2%), tobacco use (6.1%), and pulmonary disorders (5.3%). The percentage of patients with any comorbidities increased from 30.5% to 47.3% during 1997-2011 (adjusted R 2 = 0.83; P \ .001).
Results
Overall, 1846 (28.2%) suffered from at least 1 complication during their admission. This included 1714 (26.2%) patients who suffered from the neurological and 337 (5.1%) patients who suffered from the medical complications ( Table 3) . The most common neurological complication was facial nerve paralysis (8.7%). Fourteen patients died during their hospitalization, resulting in a mortality rate of 0.2%. In 4.0% (260) of cases, patients' admission ended with death or transfer to further care. There were no significant changes over time in the rates of complications or outcomes of surgeries (neurological complications P = .45; medical complications P = .61; further care/death P = .30).
The multivariate analysis revealed that the neurological complications were more likely to occur over time ( Table  4 ). The odds of the neurological complications were 1.51 (95% CI, 1.12-2.04) in the 2007-2011 time period compared to 1997-2001. The odds of out-of-state patients having a neurological complication were 1.82 (95% CI, 1.22-2.72). Patients with comorbidities were 1.48 times (95% CI, 1.16-1.88) and patients undergoing surgery in hospitals with case volume of 0-99 were 1.69 times (95% CI, 1.31-2.18) more likely to suffer from the neurological complications. Medical complications were also more likely to occur over time ( Table 4 ). The odds of the medical complications were higher in 2007-2011 (OR = 1.69; 95% CI, 1.02-2.80). Patients with private principal payers were less likely to suffer from the medical complications (OR = 0.27; 95% CI, 0.12-0.60).
The odds of patient admissions ending with further care or death was higher in females (OR = 1.64; 95% CI, 1.16-2.33) and non-Caucasians (OR = 1.64; 95% CI, 1.09-2.48) as presented in Table 4 . Out-of-state residence (OR = 2.10; 95% CI, 1.18-3.73), comorbidities (OR = 1.60; 95% CI, 1.11-2.30), and low hospital case volume (OR = 1.66; 95% 
Discussion
This retrospective study of the VS cases in California showed the changing trends in comorbidities and complications in patients undergoing surgery. The number of surgeries performed has slightly decreased, and the number of patients with comorbidities has increased, while the mean age of patients has remained the same. With the advent of better diagnostics, specifically the use of MRI, the number of VSs that are diagnosed yearly is increasing. In parallel, increasing numbers of VS cases are being serially watched, instead of immediate treatment. 2, 6, 7 Despite the current ability to detect smaller tumors, our study showed no significant change in the average age of patients who undergo surgical excision. This may reflect the trend that patients undergoing surgical resection are more carefully chosen. Although the mean age has not increased, the number of comorbidities has increased. It is likely that smaller tumors are being serially observed, and when growth of the tumor is detected, more patients of all ages are offered stereotactic radiosurgery to avoid the risk of operative complications. This indicates that patients diagnosed with larger tumors with neurological consequences, regardless of comorbid conditions, are still offered and undergo surgical resection. The overall comorbidity rate was 38.7%, with the most common comorbid conditions being hypertension (21.2%), tobacco use (6.1%), and pulmonary conditions (5.3%). Endocrine problems, such as hypothyroidism and diabetes, were present in approximately 5% of the operative cases. The rates of these comorbid conditions are less than the adult prevalence rates in the US, as determined by the Centers for Disease Control and Prevention (hypertension 31.9%, tobacco use 19.0%, pulmonary disorders 6.3%, hypothyroidism 4.6%, obesity 35.9%, and diabetes 6.9%). 17 Surgical interventions are more limited to patients who are in general much healthier than the general public. Although patients are still healthier than the general public, on metaanalysis, the presence of comorbidities in patients undergoing surgery has increased with time. This may indicate that patients are electing to watch serially their tumor growth and if the tumor does enlarge significantly, then undergo either radiosurgery or microsurgery. This rate of increase in comorbid conditions may also indicate the changing trend in hospitals in coding discharge diagnoses and comorbid conditions. The Centers for Medicare and Medicaid Services changed their hospital reimbursement methodology for determining complications and the resultant change in reimbursement in 2007. 18 With the introduction of electronic medical records, coding of comorbid conditions and complications are more easily performed and trends in clinical outcomes can also be more easily reviewed.
The overall complication rate for VS surgery was 28.2% with the majority of the complications being nervous system related (26.2%) versus non-nervous system related (5.1%). The most common postoperative complications following VS surgery have been reported as facial paralysis, hearing loss, neurologic and vascular complications, cerebrospinal fluid (CSF) leakage, meningitis, and wound infection. [4] [5] [6] 19 The most common complication in this study was nervous system complications, not elsewhere specified, at 15.2%, followed by facial nerve paralysis, which occurred in 8.7% of patients. Nervous system complications, not elsewhere specified could indicate a number of conditions, including facial nerve paresis. As shown in Table 4 , neurological complications were almost 1.5 times more likely to occur in 2007-2011 compared with 1997-2001. Two causes to this increase in the complications are presumable. One relates to the increased use of radiosurgery and watchful waiting for smaller tumors. This may have resulted in surgical cases primarily being performed in patients with larger tumors. Other authors have reported this as well. 20 The second cause of this increased reports of complications may be related to the change in the Medicare reimbursement for post-surgical complications. 18 The rates of facial nerve paralysis after VS excision vary from 3.3% to 42.5% depending on the tumor size, surgical approach, and use of intraoperative monitoring. 6 The 8.7% facial nerve paralysis rate in this study is low compared to what is documented in the literature. Given that facial nerve weakness is an expected outcome in some patients, it could be under-documented in the discharge diagnoses. Additionally, from these data, we could not determine the severity of facial paralysis as the ICD-9-CM codes would not indicate the degree of weakness or if it were transient.
The rate of CSF leakage varies greatly in the literature. Several studies showed a leak rate at approximately 9% to 13%, 21, 22 independent of surgical approach taken. Other studies have shown rates as high as 30% with a retrosigmoid approach. 23 The overall leakage rate of 3.3% in this study is low compared to the commonly cited rates in the literature and is closer to the very low CSF rates, 0.8% 24 and 1.2%, 25 as reported by some authors. The data also included patients who had CSF leaks but were managed with conservative measures, ventriculostomy, or lumbar drains, and as a result, CSF leakage may not have been listed as a discharge diagnosis. It was difficult to determine which lumbar drains were placed prophylactically and which drains were placed as a treatment for CSF leak. The rate of meningitis is also very low at 0.4%, which is similar to and slightly lower than the literature. 4, 23, 26 Mortality is low from VS surgery, usually \1% in large studies. 27 Similarly, the mortality rate in this study was 0.2%. Other medical complications of VS surgery include myocardial infarction, pneumonia, pulmonary embolism, and deep vein thrombosis. The traditional rates for these complications are similar to those for other major surgical procedures 28 and are similar to our results.
Comorbidities and low hospital case volume were associated with higher odds of neurological complications. As indicated in other studies, 11, 12, 16, 18 high volume centers have lower complications rates and shorter postoperative stays. Locations where fewer than 100 cases were performed during the 15-year study period were significantly associated with neurological complications and would need further subacute or skilled nursing care (OR = 1.81; 95% CI, 1.41-2.31, and OR = 1.66; 95% CI, 1.15-2.39, respectively). This was in agreement with other studies that indicated the hospitals or providers with the highest volumes of VS surgeries had higher frequency of routine discharges and fewer complications. 11, 12 The main limitation of this study is that our data are dependent on the discharge diagnoses that were billed or coded. These diagnosis codes often under-document the actual prevalence of these comorbid conditions and perioperative complications. This is especially true for complications such as facial paralysis. As coding is performed by hospital coders based on the notes of clinicians, many of these comorbidities and complications may not have been included in the patient's daily or discharge notes. Another limitation is that the data sets do not record the size or location of the tumors. This could also add insight to interpreting the observed trends. Given that we reviewed only the discharge diagnosis, we cannot determine the long-term complications that might ensue from VS removal, specifically if there was residual or recurrent tumor. Hearing outcome, long-term imbalance, facial nerve outcome, and tinnitus could not be addressed with this current study because of the inability to determine pre-hospitalization hearing or long-term balance or facial nerve outcomes. Additionally, given that hearing loss is often a consequence of VS surgery, specifically for a translabyrinthine approach, this diagnosis is often under-recorded.
Conclusion
We investigated the changing trends in comorbidities and complications rates in California from 1997 to 2011. The number of surgeries performed has slightly decreased, and the number of patients with comorbidities has increased, while the mean age of patients has remained the same. The presence of comorbidities and low hospital case volume were major risk factors for complications. Most complications that occurred were neurological in nature. No significant changes in risk factors for complications from vestibular schwannoma surgery were observed over the 15-year period.
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